Acomplia
Acomplia is a drug created for treating overweight, obesity and different health risks associated with these conditions. Acomplia is an appetite suppressant, which works by blocking the receptors in the central nervous system that are responsible for the feeling of hunger. In conjunction with an exercise program and diet Acomplia is regarded as a highly effective treatment for individuals that have been diagnosed with obesity or overweight.
Acomplia was developed by the French pharmaceutical company Sanofi-Aventis with the active component Rimonabant. Rimonabant is also available as a generic variation of Acomplia. In the United States Acomplia is sold under the brand name Zimulti.
Acomplia’s mechanism of action is in overall quite similar to that of Phentermine but in detail it has differences. For instance, Acomplia affects the CB1 receptors of the nervous system that have been discovered long after Phentermine has entered the marked. The CB1 receptors are responsible for the feelings of hunger and are also noted as influencing nicotine dependency. Clinical studies have shown that Acomplia has helped those overweight patients who have been struggling to quit smoking. Although it needs further investigation and approval by the authorities to be marketed as a smoking cessation drug.
Acomplia side effects
Keep in mind that Acomplia should only be taken by individuals who have been clinically diagnosed with obesity (BMI 30 kg/m?) or overweight BMI > 27 kg/m?). Do not take Acomplia if you aren’t sure about your BMI factor. Acomplia should be used in conjunction with diet and exercise program to show its full effectiveness.
People that have history of clinical depression, psychiatric conditions or going through antidepressant treatment are recommended to avoid using Acomplia, for the drug was linked to depressive thoughts during the clinical studies. If the patient was diagnosed with a psychiatric illness during Acomplia treatment the course must be stopped immediately.
Acomplia is also not recommended to be taken if the patient has one of the following conditions:
• allergic reaction to Rimonabant or any other Acomplia ingredients
• galactose intolerance or glucose-galactose malabsorption
• hepatic impairment
• renal impairment
• age over 70
• consumption of ritonavir, ketoconazole, telithromycin, itraconazole, clarithromycin or nefazodone
It is not known whether Acomplia affects the unborn baby or passes through milk so it is recommended to avoid Acomplia treatment during pregnancy or breastfeeding. If you are pregnant or plan to become pregnant inform your doctor before considering a course of Acomplia.
When taking Acomplia you can experience certain side-effects. Inform your doctor as soon as you have felt one of the following symptoms:
• nausea
• vomiting
• diarrhoea
• dry mouth
• anorexia
• depressions
• anxiety
• irritability
• nervousness
• sleep disorders
• impaired memory
• impaired attention
In case you suspect Acomplia overdose contact your doctor immediately and monitor closely your heart activity and breathing. You may experience the following symptoms as signals of Acomplia overdose: headache, fatigue, insomnia, euphoria. Do not take a double dose if you have missed the previous one!
Acomplia generic variations
Generic drugs are drugs that have the same active ingredient and effects as the branded medicine and differ only in inactive ingredients, shape and size of the tablet. Acomplia’s active ingredient is Rimonabant, which is available as a brand weight loss pill in several countries. In the US Acomplia is marketed under the name Zimulti, which is essentially the same drug as its European variation.
